Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed at $2.83 in the last session, up 9.27% from day before closing price of $2.59. In other words, the price has increased by $9.27 from its previous closing price. On the day, 0.75 million shares were traded. BDTX stock price reached its highest trading level at $2.86 during the session, while it also had its lowest trading level at $2.6.
Ratios:
We take a closer look at BDTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.24 and its Current Ratio is at 9.24. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
On July 31, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Versant Venture Capital VI, L. sold 221,600 shares of BDTX for $1,400,556 on Aug 28 ’24. The 10% Owner now owns 3,726,341 shares after completing the transaction at $6.32 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 160921152 and an Enterprise Value of 30108258. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.87. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 8.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.30 while its Price-to-Book (P/B) ratio in mrq is 1.13. Its current Enterprise Value per Revenue stands at 0.43 whereas that against EBITDA is -42.051.
Stock Price History:
The Beta on a monthly basis for BDTX is 2.93, which has changed by -0.43456542 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $6.75, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is 9.26%, while the 200-Day Moving Average is calculated to be 22.91%.
Shares Statistics:
According to the various share statistics, BDTX traded on average about 1.18M shares per day over the past 3-months and 774010 shares per day over the past 10 days. A total of 56.68M shares are outstanding, with a floating share count of 43.28M. Insiders hold about 23.88% of the company’s shares, while institutions hold 62.48% stake in the company. Shares short for BDTX as of 1752537600 were 6062461 with a Short Ratio of 5.13, compared to 1749772800 on 6835909. Therefore, it implies a Short% of Shares Outstanding of 6062461 and a Short% of Float of 15.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
